Bioelectronics Corp (BIEL)

[srinsocal]

My estimate is for the reclassification event only. The other positives in the pipeline, 510k submittal, partnership/licensing announcement, 510k approval, OTC approval, will all have their own impact on the share price. BIEL will be more like a locomotive than a rocket, picking up speed as each of these positive events kicks in.

If on the other hand the FDA, feeling the heat from pain med abuse (see TAZZER's post), should grant a special Low Voltage class of PEMF with easy OTC access in their reclassification BIEL
would blast off.